
Cheap Targeted Drug Delivery yeCancer: Mutengo Wekufunga uye Neramangwana MafambiroIchi chinyorwa chinoongorora mutengo-unoshanda wezvakachipa wakanangwa zvinodhaka kuendesa masystem ekurapwa kwegomarara, kuongorora matekinoroji aripo, nzira dziri kubuda, uye mafambiro emangwana. Tichakurukura zvinhu zvinopesvedzera mutengo, mari inogona kuchengetwa, uye kukanganisa kwese kwemurwere kuwana kurapwa kwegomarara.
Mutengo wepamusoro wekurapwa kwegomarara chinhu chakakosha chipingamupinyi mukutarisira kwakanaka pasi rose. Zvirongwa zvekuendesa zvinodhaka zvakanangwa zvinopa mhinduro inovimbisa nekuvandudza mashandiro ekurapa uku zvichikwanisa kuderedza mutengo wese wekurapwa. Ichi chinyorwa chinotarisa mukuoma kwekuwana zvakachipa zvakanangwa mushonga kuendesa kune cancer mutengo, kuongorora nzira dzakasiyana-siyana uye hukama hwadzo hwehupfumi. Tichaongorora nzira dzemazuva ano, hutsva hunovimbisa, uye tarisiro yenguva refu yekuita kuti mishonga inoponesa hupenyu iyi iwanikwe.
Nzira dzinoverengeka dzakanangwa dzekuunza zvinodhaka dziri kushandiswa pari zvino, imwe neimwe iine madhigirii akasiyana-siyana ekudhura-kushanda. Izvi zvinosanganisira:
Liposomal nanoparticles inoputira mushonga, ichidzivirira kubva mukuora uye kusimudzira kuendesa kwayo kune bundu maseru. Nepo ichipa budiriro yakavandudzwa, mutengo wekugadzira unogona kuve wakakura. Tsvagiridzo irikuenderera mberi kukwirisa maitiro ekugadzira uye kuderedza mutengo weaya masisitimu. Dzidza zvakawanda nezve liposomal nanoparticles.
ADCs inosanganisa mushonga wecytotoxic ine monoclonal antibody, yakanangana nemushonga kumasero egomarara. Mutengo wepamusoro wekugadzirwa kwemasoja ekudzivirira chirwere ndicho chinhu chikuru chinopa kudhura kwese kweADCs. Nekudaro, tsvakiridzo inoenderera inotarisana nekugadzira yakachipa nzira dzekugadzira antibody.
Polymer-based nanoparticles inopa inogona kudhura imwe nzira kune liposomal uye ADC-based system. Aya nanoparticles anogona kugadzirwa kunanga chaiwo bundu maseru uye kuburitsa mushonga nenzira inodzorwa. Iko kudhura-kushanda kweiyi nzira kunoenderana zvakanyanya neiyo chaiyo polymer inoshandiswa uye maitiro ekugadzira. Dzidza zvakawanda nezve polymer nanoparticles.
Mutengo we kutengeswa kwemishonga yakachipa yegomarara inopesvedzerwa nezvakawanda zvakakosha zvinhu:
Tsvagiridzo iri kushingairira kutsvaga nzira itsva dzekudzikisa mutengo wekuendeswa kwezvinodhaka, kusanganisira:
Kufambira mberi mune nanotechnology kuri kutungamira mukuvandudzwa kwemaitiro anoshanda uye anodhura ekugadzira nanoparticles.
Kutevedzera maitiro echisikigo ebhayoloji kunogona kutungamira kune akanyanya kushanda uye anodhura-anodhura dhizaini masisitimu.
Kugadzirisa kurapwa kune mumwe nemumwe murwere kunogona kuderedza mari isingakoshi ine chekuita nekurapa kusingashande. Iyi nzira, zvisinei, inoda kufambira mberi kwakakosha mukuongorora uye zvirongwa zvekurapa zvemunhu.
Achieving zvakachipa zvakanangwa mushonga kuendesa kune cancer mutengo rinoramba riri dambudziko rakakura, asi kutsvagisa kuri kuramba kuchiitika uye kufambira mberi kwetekinoroji kunopa nzira dzinovimbisa. Nekugadzirisa maitiro ekugadzira, kugadzira masisitimu ekutumira, uye kutarisa kune nzira dzinodhura, tinogona kuvandudza kuwanikwa kwekurapa cancer inoponesa varwere pasi rese. Kumwe kutsvagisa uye kubatirana kwakakosha kuti uone kugona kwakazara kwekutengesa kwakanangwa zvinodhaka kuendesa kenza.
Kuti uwane rumwe ruzivo nezve advanced cancer research uye nzira dzekurapa, shanya iyo Shandong Baofa Cancer Research Institute.
p>
parutivi>
body>